Short-Term Debt to Equity Ratio: Sage Therapeutics, Inc. (SAGE)
The daily price chart for Sage Therapeutics, Inc. (SAGE) reflects the dynamics of a company creating a closed-loop ecosystem for postpartum depression therapy with client acquisition through maternity hospitals, where the indicator stands at 0.00. The business relies on medical professionals' trust in unique mental recovery treatments and delegates drug production to external contractors while maintaining strict internal oversight of product quality.
Analytical breakdowns and data insights for company sagerx.com (SAGE)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Sage Therapeutics, Inc.|SAGE - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Sage Therapeutics|SAGE - Company Aggregate Debts|Debts to Book Capitalization Sage Therapeutics Inc.|SAGE - Long-Term Indebtedness|Company Short-Term Debts Sage Therapeutics|Quick Liquidity Indicator sagerx.com
- company profitability and valuation multiples indicators:
Comprehensive company analysis:Sage Therapeutics, Inc
To find fundamental support for Sage Therapeutics, Inc. (SAGE), which is commercializing the innovative drug Zurzuvae for PDD therapy, it is critical to analyze the short-term debt to equity chart, which compares liabilities maturing within one year to shareholders' equity, allowing for an assessment of the company's short-term liquidity and financial leverage stability during an active product rollout phase.
Competitor analysis
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|Short-Term Debt to Equity Catalyst Pharmaceuticals|denalitherapeutics.com (DNLI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital HRMY|Short-Term Debt to Capital Biohaven Ltd (BHVN)|Short-Term Debt to Capital AMLX (Amylyx)|Short-Term Indebtedness to Equity Trevi Corp|Praxis Precision Medicines - Short-Term Debt to Capital|Current Liabilities to Capital anavex.com|CBLL (CeriBell) - Short-Term Debt to Equity Ratio|Prothena Biosciences - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ALEC|ANNX (Annexon Biosciences Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital OMER|NGNE (neurogene.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ACIU (AC Immune SA)|Voyager Therapeutics Inc (VYGR) - Current Liabilities to Capital|NMRA - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital SCLX (Scilex Holding Company, Inc.)|TVGN: Short-Term Debt to Capital|Alpha Cognition Inc. (ACOG) - Short-Term Debt to Capital|Short-Term Debt to Equity Cognition Therapeutics, Inc.|Inhibikase Therapeutics Inc - Current Liabilities to Equity|Short-Term Debt to Capital SAVA|ASRT - Current Liabilities to Capital|Coya Therapeutics - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital VistaGen Therapeutics, Inc. VTGN|OVID: Short-Term Debt to Equity Ratio|Acumen Pharmaceuticals Inc. - Short-Term Loans to Capital Ratio|CRVO: Short-Term Debt to Capital|ATHE - Short-Term Debt to Capital Coefficient|CLNN (Clene Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PepGen Corp (PEPG)|Short-Term Debt to Equity Jupiter Neurosciences (JUNS)|Short-Term Debt to Capital Coefficient Relmada Therapeutics Inc|Annovis Bio Corp - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital GRCE|Firefly Neuroscience, Inc - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Klotho Neurosciences Inc KLTO|neurosense-tx.com (NRSN) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio RVPH|MTVA (MetaVia Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio NeurAxis Inc (NRXS)|Short-Term Debt to Equity Ratio HSDT (Helius Medical)|Short-Term Debt to Capital Coefficient passagebio.com|Short-Term Debt to Equity Neuphoria Therapeutics NEUP|Short-Term Debt to Capital Coefficient Minerva Neurosciences Inc (NERV)|Athira - Short-Term Debt to Capital|ADXN - Short-Term Debt to Capital|ALZN: Short-Term Debt to Capital|Short-Term Indebtedness to Equity Cyclerion Therapeutics, Inc. CYCN|PTIX (Protagenic Therapeutics Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Pasithea KTTA|Short-Term Debt to Equity Cortigent, Inc. (CRGT)|Avenue Therapeutics Inc - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital BCLI (Brainstorm Cell)|caratherapeutics.com (CARA) - Current Liabilities to Capital|CHRO: Short-Term Debt to Equity Ratio|ELYM - Short-Term Debt to Capital|intracellulartherapies.com (ITCI) - Short-Term Debt to Equity|Longboard - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Marinus Pharmaceuticals|Current Liabilities to Capital nkgenbiotech.com NKGN|Short-Term Debt to Equity NeuroBo Pharmaceuticals, Inc. (NRBO)|Short-Term Debt to Capital Coefficient Synaptogenix Inc.|Short-Term Debt to Capital TRVN (Trevena, Inc)|Short-Term Debt to Capital Vigil Neuroscience Inc. VIGL|Anew Medical, Inc. - Short-Term Debt to Capital|Short-Term Indebtedness to Equity cerevel.com (CERE)